Consolidated EBITDA increased by 36% y-o-y to Rs. 2,340 million; EBITDA margins increased by 305 bps y-o-y to 27.4% in Q3 FY24 Net Profit grew by 53% y-o-y to Rs. 1,235 million Both matured and developing hospitals reported strong revenue growth of 17% and 33% in
Global Health Limited (NSE: Medanta, BSE: 543654), one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, today announced its unaudited consolidated financial results for the quarter and nine months ending 31st December, 2022. Highlights of the Nine
